279 related articles for article (PubMed ID: 12566438)
1. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N; Luberto C; Hannun YA
J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
[TBL] [Abstract][Full Text] [Related]
2. Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae.
Sawai H; Okamoto Y; Luberto C; Mao C; Bielawska A; Domae N; Hannun YA
J Biol Chem; 2000 Dec; 275(50):39793-8. PubMed ID: 11006294
[TBL] [Abstract][Full Text] [Related]
3. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
[TBL] [Abstract][Full Text] [Related]
4. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.
Marchesini N; Osta W; Bielawski J; Luberto C; Obeid LM; Hannun YA
J Biol Chem; 2004 Jun; 279(24):25101-11. PubMed ID: 15051724
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
6. Purification of neutral sphingomyelinase 2 from bovine brain and its calcium-dependent activation.
Kim SK; Ahn KH; Jeon HJ; Lee DH; Jung SY; Jung KM; Kim DK
J Neurochem; 2010 Feb; 112(4):1088-97. PubMed ID: 19968763
[TBL] [Abstract][Full Text] [Related]
7. Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C.
Sawai H; Domae N; Nagan N; Hannun YA
J Biol Chem; 1999 Dec; 274(53):38131-9. PubMed ID: 10608884
[TBL] [Abstract][Full Text] [Related]
8. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
9. Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.
Airola MV; Shanbhogue P; Shamseddine AA; Guja KE; Senkal CE; Maini R; Bartke N; Wu BX; Obeid LM; Garcia-Diaz M; Hannun YA
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5549-E5558. PubMed ID: 28652336
[TBL] [Abstract][Full Text] [Related]
10. Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium.
Kim SK; Ahn KH; Ji JE; Choi JM; Jeon HJ; Jung SY; Jung KM; Kim DK
Cell Signal; 2010 May; 22(5):865-70. PubMed ID: 20096352
[TBL] [Abstract][Full Text] [Related]
11. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
[TBL] [Abstract][Full Text] [Related]
12. Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation.
Devillard R; Galvani S; Thiers JC; Guenet JL; Hannun Y; Bielawski J; Nègre-Salvayre A; Salvayre R; Augé N
PLoS One; 2010 Mar; 5(3):e9826. PubMed ID: 20352118
[TBL] [Abstract][Full Text] [Related]
13. Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase.
Clarke CJ; Mediwala K; Jenkins RW; Sutton CA; Tholanikunnel BG; Hannun YA
J Biol Chem; 2011 Jun; 286(24):21565-76. PubMed ID: 21536668
[TBL] [Abstract][Full Text] [Related]
14. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
15. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
16. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.
Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA
J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762
[TBL] [Abstract][Full Text] [Related]
17. Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein.
Krut O; Wiegmann K; Kashkar H; Yazdanpanah B; Krönke M
J Biol Chem; 2006 May; 281(19):13784-13793. PubMed ID: 16517606
[TBL] [Abstract][Full Text] [Related]
18. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
Matmati N; Hannun YA
J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
[TBL] [Abstract][Full Text] [Related]
20. Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt.
Qin J; Berdyshev E; Poirer C; Schwartz NB; Dawson G
J Biol Chem; 2012 Apr; 287(17):13620-32. PubMed ID: 22383528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
